GSA Capital Partners LLP Makes New Investment in ACADIA Pharmaceuticals Inc. $ACADMarket Beat·Aug 17 at 04:36 AMACAD+1.58%
Biotech Stocks At 52-Week Highs - BIVI +22%, XNCR, ANRO, HAE, ACADrttnews·Aug 13 at 03:30 AMANRO+0.09%ACAD+1.58%
ACADIA Pharmaceuticals Expands DAYBUE, NUPLAZID Reach Ahead of Key Alzheimer’s DataMarket Beat·Aug 12 at 02:04 PMACAD+1.58%
ACAD: DAYBUE STIX is quickly overtaking the original formulation as European launch preparations advanceQuartr·Aug 12 at 01:41 PMACAD+1.58%
Mark Schneyer Sells 5,849 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) StockMarket Beat·Aug 7 at 06:08 PMACAD+1.58%
Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52PUBT·Aug 7 at 05:00 PMACAD+1.58%
Guggenheim Sticks to Its Hold Rating for ACADIA Pharmaceuticals (ACAD)Tip Ranks·Aug 5 at 03:25 PMACAD+1.58%
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, Citizens Jmp Analyst SaysMarket Beat·Aug 5 at 10:24 AMACAD+1.58%
Mizuho Securities Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)Tip Ranks·Aug 4 at 10:35 PMACAD+1.58%
Acadia Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 307.96 MEarnings Watch·Aug 4 at 03:56 PMACAD+1.58%
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results | ACAD Stock NewsStockTitan·Aug 4 at 07:05 AMACAD+1.58%
10:31 ETDementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsightprnewswire·Aug 3 at 09:31 AMBMY+2.35%ACAD+1.58%
The Manufacturers Life Insurance Company Raises Stock Holdings in ACADIA Pharmaceuticals Inc. $ACADMarket Beat·Aug 3 at 04:12 AMACAD+1.58%UBS+0.17%
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference | ACAD Stock NewsStockTitan·Jul 30 at 08:57 AMACAD+1.58%
How FDA Fast Track For Remlifanserin In Alzheimer’s Psychosis At ACADIA (ACAD) Has Changed Its Investment StorySimplywall·Jul 27 at 10:16 PMACAD+1.58%
